160 related articles for article (PubMed ID: 26713668)
21. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
[TBL] [Abstract][Full Text] [Related]
22. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
Ye J; Xu YK; Liu X; Lü GS
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
[TBL] [Abstract][Full Text] [Related]
23. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies.
Mortezazadeh T; Gholibegloo E; Alam NR; Dehghani S; Haghgoo S; Ghanaati H; Khoobi M
MAGMA; 2019 Aug; 32(4):487-500. PubMed ID: 30730021
[TBL] [Abstract][Full Text] [Related]
24. A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.
Kalber TL; Kamaly N; So PW; Pugh JA; Bunch J; McLeod CW; Jorgensen MR; Miller AD; Bell JD
Mol Imaging Biol; 2011 Aug; 13(4):653-62. PubMed ID: 20809208
[TBL] [Abstract][Full Text] [Related]
25. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
[TBL] [Abstract][Full Text] [Related]
26. Cancer cell targeting and imaging with biopolymer-based nanodevices.
Hajdu I; Bodnár M; Trencsényi G; Márián T; Vámosi G; Kollár J; Borbély J
Int J Pharm; 2013 Jan; 441(1-2):234-41. PubMed ID: 23246780
[TBL] [Abstract][Full Text] [Related]
27. Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.
Ahmed A; Zhang C; Guo J; Hu Y; Jiang X
Macromol Biosci; 2015 Aug; 15(8):1105-14. PubMed ID: 25846258
[TBL] [Abstract][Full Text] [Related]
28. Stability and trapping of magnetic resonance imaging contrast agents during high-intensity focused ultrasound ablation therapy.
Hijnen NM; Elevelt A; Grüll H
Invest Radiol; 2013 Jul; 48(7):517-24. PubMed ID: 23695082
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
30. Targeted Fe-filled carbon nanotube as a multifunctional contrast agent for thermoacoustic and magnetic resonance imaging of tumor in living mice.
Ding W; Lou C; Qiu J; Zhao Z; Zhou Q; Liang M; Ji Z; Yang S; Xing D
Nanomedicine; 2016 Jan; 12(1):235-44. PubMed ID: 26393884
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
[TBL] [Abstract][Full Text] [Related]
32. Poly(glycerol) Used for Constructing Mixed Polymeric Micelles as T
Cao Y; Liu M; Zhang K; Zu G; Kuang Y; Tong X; Xiong D; Pei R
Biomacromolecules; 2017 Jan; 18(1):150-158. PubMed ID: 28064499
[TBL] [Abstract][Full Text] [Related]
33. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging of osteosarcoma using a bis(alendronate)-based bone-targeted contrast agent.
Ge P; Sheng F; Jin Y; Tong L; Du L; Zhang L; Tian N; Li G
Biomed Pharmacother; 2016 Dec; 84():423-429. PubMed ID: 27682736
[TBL] [Abstract][Full Text] [Related]
35. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
[TBL] [Abstract][Full Text] [Related]
36. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.
Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T
Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640
[TBL] [Abstract][Full Text] [Related]
37. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
[TBL] [Abstract][Full Text] [Related]
38. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
[TBL] [Abstract][Full Text] [Related]
39. Green Synthesis of Sub-10 nm Gadolinium-Based Nanoparticles for Sparkling Kidneys, Tumor, and Angiogenesis of Tumor-Bearing Mice in Magnetic Resonance Imaging.
Zhang B; Yang W; Yu J; Guo W; Wang J; Liu S; Xiao Y; Shi D
Adv Healthc Mater; 2017 Feb; 6(4):. PubMed ID: 28004887
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
